idelalisib and Primary-Immunodeficiency-Diseases

idelalisib has been researched along with Primary-Immunodeficiency-Diseases* in 1 studies

Other Studies

1 other study(ies) available for idelalisib and Primary-Immunodeficiency-Diseases

Article	Year
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in Proceedings of the National Academy of Sciences of the United States of America, 2017, 02-21, Volume: 114, Issue:8 Activated PI3K Delta Syndrome (APDS) is a primary immunodeficiency disease caused by activating mutations in either the leukocyte-restricted p110δ catalytic ( Topics: Catalytic Domain; Cell Membrane; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Enzyme Assays; Enzyme Inhibitors; Gain of Function Mutation; Humans; Immunologic Deficiency Syndromes; Mass Spectrometry; Models, Molecular; Phenotype; Phosphatidylinositol 3-Kinases; Primary Immunodeficiency Diseases; Protein Conformation; Purines; Quinazolinones; Randomized Controlled Trials as Topic; Sequence Deletion	2017

Article

Year

Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in

Proceedings of the National Academy of Sciences of the United States of America, 2017, 02-21, Volume: 114, Issue:8

Activated PI3K Delta Syndrome (APDS) is a primary immunodeficiency disease caused by activating mutations in either the leukocyte-restricted p110δ catalytic (

Topics: Catalytic Domain; Cell Membrane; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Enzyme Assays; Enzyme Inhibitors; Gain of Function Mutation; Humans; Immunologic Deficiency Syndromes; Mass Spectrometry; Models, Molecular; Phenotype; Phosphatidylinositol 3-Kinases; Primary Immunodeficiency Diseases; Protein Conformation; Purines; Quinazolinones; Randomized Controlled Trials as Topic; Sequence Deletion

2017